NASDAQ:TTRX | Cash Flow Statement | Turn Therapeutics Inc.

Complete source-backed cash-flow history.

Available history
2024-09-30 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$5.85M
2026-03-31-$970,972.00-$1.63M-$12,227.00$7.79M
2025-12-31$279,070.00-$1.18M-$31,441.00$3.18M
2025-09-30-$1.9M
2025-06-30-$1.24M
2025-03-31-$328,547.00-$298,058.00$998,092.00
2024-12-31-$323,130.00-$430,545.00-$7,842.00$522,206.00
2024-09-30-$666,442.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$3.19M-$2.56M-$152,986.00$6.92M
2024-12-31-$1.77M-$1.36M-$99,475.00$1.15M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.